Skin Diseases Completed Phase 2 Trials for Benralizumab (DB12023)

Also known as: Skin Disease / Iatrogenic dermatosis / Disease of skin (disorder) / Skin disorder / Dermatosis / Skin disorder NOS

IndicationStatusPhase
DBCOND0028161 (Skin Diseases)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03563066Effect of Benralizumab in Atopic DermatitisTreatment